Brian Till, MD

faculty member

Brian Till, MD

Associate Professor
Translational Science and Therapeutics Division, Fred Hutch

Fax: 206.667.1874
Mail Stop: D3-100

Dr. Brian Till develops new treatments for lymphoma by genetically engineering a patient's own T cells so they can more effectively attack cancer. T cells target and kill cancer cells by binding to specific proteins on the tumor cells with molecules called T-cell receptors. Dr. Till's research involves making synthetic receptors known as chimeric antigen receptors, or CARs, that home in on lymphoma cells. He led the first published trial testing CAR T cells as a treatment for lymphoma patients. Dr. Till continues to carry out a variety of immunological, genetic and gene-expression studies in the clinic to understand why CAR T-cell therapies work for some patients and fail for others. This research will help improve the next iterations of this experimental therapy.

Other Appointments & Affiliations

Associate Professor of Medicine
University of Washington

Attending Physician, Stem Cell Transplant Service
Fred Hutchinson Cancer Center

Attending Physician, Immunotherapy Service
Fred Hutchinson Cancer Center


Research Associate, Fred Hutchinson Cancer Research Center, 2008-2011

Senior Fellow, Medical Oncology, Fred Hutchinson Cancer Research Center and UW, 2005-2008

Resident, Internal Medicine, Hospital of the University of Pennsylvania, 2002-2005

MD, University of Chicago, 2002

BS, Biology, The Catholic University of America, Washington, DC, 1998

"To see something that came from my lab put a patient with bad lymphoma into remission — it’s super gratifying to see that."

— Dr. Brian Till

Find an Active Clinical Trial Led by Dr. Till

Dr. Till in the News

Hopes and predictions for 2022

Hutch News - December 21, 2021

Learning more from T-cell therapy trials

Hutch News - March 28, 2018

CAR T cells manufacture upgrades

Science Spotlight - January 15, 2018

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210